<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DD71419B-D98D-4F0F-B816-B5662CEB7116"><gtr:id>DD71419B-D98D-4F0F-B816-B5662CEB7116</gtr:id><gtr:name>NIH Clinical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7D345B1E-E46C-414F-830C-DF9F586987AF"><gtr:id>7D345B1E-E46C-414F-830C-DF9F586987AF</gtr:id><gtr:name>Faculty of Life Sciences and Medicine</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1D963404-E8A7-4202-9456-1FF57DBB985B"><gtr:id>1D963404-E8A7-4202-9456-1FF57DBB985B</gtr:id><gtr:name>UCL Cancer Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Medicine School Office</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DD71419B-D98D-4F0F-B816-B5662CEB7116"><gtr:id>DD71419B-D98D-4F0F-B816-B5662CEB7116</gtr:id><gtr:name>NIH Clinical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7D345B1E-E46C-414F-830C-DF9F586987AF"><gtr:id>7D345B1E-E46C-414F-830C-DF9F586987AF</gtr:id><gtr:name>Faculty of Life Sciences and Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1D963404-E8A7-4202-9456-1FF57DBB985B"><gtr:id>1D963404-E8A7-4202-9456-1FF57DBB985B</gtr:id><gtr:name>UCL Cancer Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/5E6FF395-677E-42C2-95A6-13300F3DB744"><gtr:id>5E6FF395-677E-42C2-95A6-13300F3DB744</gtr:id><gtr:firstName>Grzegorz</gtr:firstName><gtr:surname>Woszczek</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0900536"><gtr:id>FECBE04D-8FAD-4E0C-85BD-2960512AAE19</gtr:id><gtr:title>Leukotriene E4 receptors in asthma pathogenesis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0900536</gtr:grantReference><gtr:abstractText>The incidence of bronchial asthma has increased during last two decades in the UK, affecting more than 5 million people and putting the UK in the first place among European countries with the highest prevalence of the disease. In spite of great efforts we still do not fully understand the primary mechanisms leading to development of asthmatic symptoms. Cysteinyl leukotrienes (cysLTs) appear to be one of the major substances causing asthma and asthmatic lungs are very sensitive to the effects of these substances, especially to leukotriene E4 (LTE4). This disproportionate sensitivity to LTE4 is even more increased in a subpopulation of patients with aspirin-sensitive asthma. We propose to characterise new receptors for cysLTs and define the way that cysLTs exert their action on lung cells. Our research will allow an understanding of the role of the cysLTs in the mechanism of bronchial asthma and may lead to new treatments.</gtr:abstractText><gtr:technicalSummary>Basic and clinical studies have indicated that cysteinyl leukotrienes (cysLTs) are one of the major proinflammatory mediators involved in the pathophysiology of bronchial asthma. Although leukotrienes have been known for more than 20 years we still do not fully understand their signalling and functions in pathological processes such as bronchial asthma. 
Asthmatic airways respond with enhanced bronchoconstriction to inhaled cysLTs and especially to leukotriene E4 (LTE4) in comparison with normal subjects. This disproportionate hyperresponsiveness to LTE4 is even more increased in a subpopulation of asthmatics (about 10% of asthmatics), with aspirin-sensitive asthma. LTE4 has also been shown to be the most potent cysLT in eliciting influx of inflammatory cells such as eosinophils and basophils into bronchial mucosa of asthmatic subjects. None of these phenotypes can be explained based on current knowledge of cysLT signalling through their specific receptors. The existence of separate LTE4 receptors has been recently postulated. The P2Y12 has been suggested to be a novel LTE4 receptor in human cells and another, as yet unidentified LTE4 receptor has been described in CysLT1/CysLT2 double knock-out murine model. Our goal is to characterise the P2Y12 as the LTE4 specific receptor in human primary cells, define the human P2Y12 gene structure, including promoter and alternatively spliced transcript expression and mechanisms responsible for regulation of the receptor expression. To address whether P2Y12 may have a role in asthma pathogenesis, the receptor expression at the mRNA level as well responsiveness to LTE4 will be studied in cells derived from asthmatic patients in comparison to healthy control subjects. The role of currently used P2Y12 inhibitors as a potential, new anti-asthmatic drugs will be evaluated in in vitro models. Clinical data showing increased LTE4 responsiveness in asthmatic patients strongly suggest that an additional LTE4 receptor is expressed on airway smooth muscle cells, apart from P2Y12, with enhanced expression in asthmatics and with the highest expression present in bronchi of aspirin sensitive subjects. In order to identify this novel LTE4 receptor we will characterise the pattern of G-protein coupled receptor (GPCR) expression and LTE4-induced signalling in cells from asthmatics with different asthma phenotypes and healthy controls using real-time PCR array and calcium mobilization assay. Identified genes will be cloned, expressed heterologously and analysed for LTE4 responsiveness.
This project presents a unique opportunity to provide important insights on the role of LTE4 in asthma and the possibility of identifying new molecular targets for patient benefit.</gtr:technicalSummary><gtr:fund><gtr:end>2013-07-24</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-01-25</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>497294</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Biomedical Sciences KCL</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Physiology</gtr:department><gtr:description>Airway smooth muscle culture from bronchial biopsies</gtr:description><gtr:id>5723BBFE-1958-40A5-A8E7-F184AA17238D</gtr:id><gtr:impact>Setting up a unique model to study human airways. Research projects in progress.</gtr:impact><gtr:partnerContribution>Selection of patients, performing bronchoscopies and collecting biopsies.
Culture of human airway smooth muscle</gtr:partnerContribution><gtr:piContribution>Setting the method for in vitro culture of human airway smooth muscle from bronchial biopsies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London (ICL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>GPCR Imperial</gtr:description><gtr:id>B5F9C7F5-997B-4A4B-B7D0-56AD725A0FE4</gtr:id><gtr:impact>PMID: 22391114</gtr:impact><gtr:partnerContribution>Collaboration on research on G-protein coupled receptors in immune responses.
-Intelectual input
-Access to facilities</gtr:partnerContribution><gtr:piContribution>Collaboration on research on G-protein coupled receptors in immune responses. 
PMID: 22391114</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London (KCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>NIHR Biomedical Research Centre</gtr:department><gtr:description>NIHR BRC</gtr:description><gtr:id>08330177-F4B8-4CD0-AA52-0F6CC4770F41</gtr:id><gtr:impact>PMID: 23472176; PMID: 22391114</gtr:impact><gtr:partnerContribution>Access to clinical and research facilities. Training.</gtr:partnerContribution><gtr:piContribution>Collaboration - research projects on asthma and allergy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London (KCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Respiratory Medicine and Allergy</gtr:department><gtr:description>Airway smooth muscle culture from bronchial biopsies</gtr:description><gtr:id>2FB49677-A451-47A2-97ED-205515F8A6F5</gtr:id><gtr:impact>Setting up a unique model to study human airways. Research projects in progress.</gtr:impact><gtr:partnerContribution>Selection of patients, performing bronchoscopies and collecting biopsies.
Culture of human airway smooth muscle</gtr:partnerContribution><gtr:piContribution>Setting the method for in vitro culture of human airway smooth muscle from bronchial biopsies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Faculty of Life Sciences and Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Asthma, Allergy and Lung Biology</gtr:department><gtr:description>GPCRs King's</gtr:description><gtr:id>A01D9BF5-63E0-4760-9E2F-E19C11884843</gtr:id><gtr:impact>PMID: 23472176; PMID: 22391114</gtr:impact><gtr:partnerContribution>Collaboration on several projects studying role of G-protein coupled receptors in asthma and allergy.
-Intellectual input
-Access to facilities
-Training of staff</gtr:partnerContribution><gtr:piContribution>Collaboration on several projects studying role of G-protein coupled receptors in asthma and allergy.
PMID: 23472176; PMID: 22391114</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>NIH Clinical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Critical Care Medicine Department (CCMD)</gtr:department><gtr:description>Collaboration with Critical Care Medicine Department, NIH, Bethesda, USA</gtr:description><gtr:id>A99AE5E9-6D3F-48D5-97D3-9C64BD909A16</gtr:id><gtr:impact>Publication:
Chen LY, Eberlein M, Alsaaty S, Martinez-Anton A, Barb J, Munson PJ, Danner RL, Liu Y, Logun C, Shelhamer JH, Woszczek G.Cooperative and redundant signaling of leukotriene B4 and leukotriene D4 in human monocytes.Allergy. 2011 Oct;66(10):1304-11. PMID: 21605126</gtr:impact><gtr:partnerContribution>Research project on leukotriene signalling in human primary cells</gtr:partnerContribution><gtr:piContribution>Project design, collaboration on experiments and data analysis.
PMID: 21605126</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>UCL Cancer Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Medical Genomics</gtr:department><gtr:description>Leukotriene receptors</gtr:description><gtr:id>4CD2706C-14ED-4973-83B3-1124C00C5F46</gtr:id><gtr:impact>Publication</gtr:impact><gtr:partnerContribution>Principal investigators of the project on comparative primate methylome analysis.</gtr:partnerContribution><gtr:piContribution>Research collaboration on the project concerning leukotriene receptors.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Asthma UK Travel Award</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Asthma UK</gtr:fundingOrg><gtr:id>372F35EF-1ECC-4C65-9E24-A5C1E752CF11</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4400</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Biomedical Research Centre</gtr:department><gtr:description>BRC Early Career Awards</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>King's College London (KCL)</gtr:fundingOrg><gtr:id>68424A62-7080-451E-86F9-3CA715E662CE</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Asthma UK Travel Award</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Asthma UK</gtr:fundingOrg><gtr:id>E3DD8220-F36F-4EB2-BA4E-6496850CBFF2</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BSI travel award</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>British Society For Immunology</gtr:fundingOrg><gtr:id>2416D0B7-DA32-458D-B99F-6DDB816DB3BE</gtr:id><gtr:sector>Learned Society</gtr:sector><gtr:start>2013-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Advances in mechanisms of allergy and clinical immunology in 2012</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>FDBED1DD-7CDA-40A6-A917-D962E98F7C05</gtr:id><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>IUPHAR review</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>A8F90295-9944-4E3C-9F43-B9EDAE291B25</gtr:id><gtr:type>Citation in systematic reviews</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Airway smooth muscle cell lines grown from endobronchial biopsies from healthy and asthmatic individuals.</gtr:description><gtr:id>3FCFE8FF-0443-4E98-BF03-2AB834FA9E10</gtr:id><gtr:impact>Development of human primary cell model used for in vitro research on airway smooth muscle cells. This model is used for predicting airway responses in health and disease states. It may replace animal models for some experiments.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Airway smooth muscle cell lines from healthy and asthmatic individuals</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9D5BF7CA-90E0-483D-80A3-A2ED9D06ADEE"><gtr:id>9D5BF7CA-90E0-483D-80A3-A2ED9D06ADEE</gtr:id><gtr:title>Cooperative and redundant signaling of leukotriene B4 and leukotriene D4 in human monocytes.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/305815f8327f691be920b61d65f0a5ba"><gtr:id>305815f8327f691be920b61d65f0a5ba</gtr:id><gtr:otherNames>Chen LY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B9E5E59C-B3CE-498F-9F7F-39A3A28F74B6"><gtr:id>B9E5E59C-B3CE-498F-9F7F-39A3A28F74B6</gtr:id><gtr:title>Sphingosine-1-phosphate induces pro-remodelling response in airway smooth muscle cells.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5e55e455f4eb90cc8c18ad11295dc264"><gtr:id>5e55e455f4eb90cc8c18ad11295dc264</gtr:id><gtr:otherNames>Fuerst E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CBA2BE60-A356-484E-9B48-8A44F970C5F8"><gtr:id>CBA2BE60-A356-484E-9B48-8A44F970C5F8</gtr:id><gtr:title>Leukotriene E4: perspective on the forgotten mediator.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/30b60407215c7023f5e04e2d639b4c3d"><gtr:id>30b60407215c7023f5e04e2d639b4c3d</gtr:id><gtr:otherNames>Lee TH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/623F8273-5205-4F98-A23E-CE423C95D277"><gtr:id>623F8273-5205-4F98-A23E-CE423C95D277</gtr:id><gtr:title>Leukotriene E4 is a full functional agonist for human cysteinyl leukotriene type 1 receptor-dependent gene expression.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6bbaa8203898ceb76c81b5cf731a7700"><gtr:id>6bbaa8203898ceb76c81b5cf731a7700</gtr:id><gtr:otherNames>Foster HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A60684D9-2FA4-4EB5-BE46-692685820FEC"><gtr:id>A60684D9-2FA4-4EB5-BE46-692685820FEC</gtr:id><gtr:title>Characterisation of P2Y(12) receptor responsiveness to cysteinyl leukotrienes.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6bbaa8203898ceb76c81b5cf731a7700"><gtr:id>6bbaa8203898ceb76c81b5cf731a7700</gtr:id><gtr:otherNames>Foster HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A123720D-2FA9-4923-AAAD-47FE2EDF8187"><gtr:id>A123720D-2FA9-4923-AAAD-47FE2EDF8187</gtr:id><gtr:title>Human T(H)2 cells respond to cysteinyl leukotrienes through selective expression of cysteinyl leukotriene receptor 1.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5432c8a7f090e2afa334f24a9a10ffc7"><gtr:id>5432c8a7f090e2afa334f24a9a10ffc7</gtr:id><gtr:otherNames>Parmentier CN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900536</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>